FDA WARNING_LETTER - Ecig.com

The FDA issued a Warning Letter to Stefan Gol regarding the sale of e-liquid products on ecig.com. The Center for Tobacco Products determined that "The Drip Company Triple Berry e-liquid" is a tobacco product under section 201(rr) of the FD&C Act and is misbranded under section 903(a)(7)(B) because it was sold to a person younger than 18 years of age.

This sale violates 21 C.F.R. § 1140.14(b), which prohibits retailers from selling covered tobacco products, including e-liquids, to individuals under 18. The FDA's investigation confirmed a minor purchased the specified e-liquid from the website.

The letter requires immediate correction of this violation and similar issues, ensuring all tobacco products, labeling, and advertising comply with the FD&C Act and FDA regulations across all sales channels. Failure to comply may result in civil money penalties, no-tobacco-sale orders, criminal prosecution, seizure, or injunction. A written response detailing corrective actions and a compliance plan is required within 15 working days, referencing number RW1700764.